Virilitas Labs
PrivateLast Round
Seed
Feb 1, 2025
Total Funding Raised
$130,000
Company Overview
Virilitas Labs is a clinics/outpatient services company that operates a male reproductive health platform intended to advance understanding, diagnostics, and support across the fertility journey.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Medical Devices, Patient Engagement, Telemedicine
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales, Usage-Based SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virilitas Labs Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Virilitas Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 1, 2025 |
Virilitas Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of East Anglia | Seed |
| Anglia Capital Group | Seed |
Virilitas Labs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Virilitas Labs's valuation, stock price, and market status.